Engineered Receptors Help the Immune System Home in on Cancer
UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer therapies with minimal side effects.
University of California San Francisco
Give to UCSF
Displaying 1 - 30 of 299
-
-
How this ‘Switchable’ CAR-T Therapy Sets its Sights on Deadly Brain Cancer
In June, UCSF treated its first patient with E-SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This story builds on previous coverage to provide an overview of CAR-T therapy, accessibility and future horizons of applications in cancer and other illnesses like HIV.
-
How the Keto Diet Could One Day Treat Autoimmune Disorders
A study shows how the keto diet affects the microbiome in ways that may reduce autoimmune responses in the gut.
-
How the Oral Microbiome is Connected to Overall Human Health
Oral health has long been siloed from the rest of a person's health. But increasingly, researchers and clinicians, including those at UCSF, are finding ties between a person's oral health and their overall health.
-
UCSF Breaks Ground on Bakar Research and Academic Building
UCSF officially broke ground on the Barbara and Gerson Bakar Research and Academic Building on Sept. 28, which will house state-of-the-art research facilities, and will also serve as the new home for the UCSF School of Nursing.
-
Precision Breast Cancer Trial Shows Improved Treatment by Tumor Subtype
Breast cancer is the second leading cause of cancer deaths in the U.S. and worldwide, pointing to the continuing need to improve treatment strategies and therapies that better patient survival and
-
Is Now the Time for a New COVID-19 Shot?
An extra-long summer surge driven by new variants has prompted the early release of updated COVID-19 vaccines. A UCSF expert tells us what new vaccines could mean for the summer surge, who should get vaccinated, and when/where to get your vaccines.
-
All Your Questions About New Covid Shots, Answered
-
Expert: Here’s What to Know About the MPox Outbreak Emergency
Seth Blumberg, MD, PhD, explains the viral disease mpox, and what the recent emergency declaration from the World Health Organization means for us.
-
Giving an Antibiotic to All Children Under 5 in Africa Saves Lives
A study determines that a life-saving, inexpensive antibiotic, azithromycin, must be given to all children up to 5 years old in Sub-Sharan Africa to realize its full potential.
-
COVID-19 Masks: Expert Tips for What You Should (and Shouldn’t) Do
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
-
‘Relentless’ New COVID Variants Extend California’s Summer Wave
-
What to Know About Long COVID and How to Reduce Your Risk
Researchers Micheal Peluso and Valerie Flaherman answer questions about what we know about one of COVID’s most enduring mysteries, including how to potentially reduce your risk and who is most likely to develop long COVID.
-
This May Be the Most Overlooked COVID Symptom
-
‘Visionary’ Study Finds Inflammation, Evidence of COVID Virus Years After Infection
-
Feeling Rough After Your COVID Shot? Congrats, It’s Working!
Adverse symptoms from the COVID-19 vaccine such as chills and headaches are linked to a robust antibody response, indicating increased efficacy compared with recipients who did not experience side effects.
-
Doctors Exploring Possible Link Between COVID and Cancer
-
How Space Research Helps Fight Infection and Aging Back on Earth
Liver samples that spent two months in the International Space Station will be studied to observe how microgravity ages liver cells and impacts their ability to regenerate. Understanding how aging damages the liver – and ways to potentially reverse that damage – could pave the way for better prevention and treatment of liver disease.
-
What to Know about the New Transmissible COVID-19 Variants
-
There’s a New Highly Transmissible COVID-19 Variant. Could FLiRT Lead to a Summer Uptick?
-
Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s
-
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
-
Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
-
Clusters of Whooping Cough Reported at Private High School in San Francisco
-
Just Ask: Patients in the ER Are Willing to Get a Flu Shot
Intentional flu vaccine messaging, such as a brief video, flyer, or a scripted provider question, is enough to persuade many who visit emergency departments to receive the vaccination.
-
The 2024 American Measles Outbreak
-
COVID-19 Virus Can Stay in the Body More Than a Year after Infection
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended.
-
COVID Vaccines Are Safe for Pregnant Women and Babies
A first of its kind study finds that the COVID vaccine is safe to administer during pregnancy, causing no abnormal delays when the infants were tested at 12 months and again at 18 months.
-
First Tissue Bank May Help Solve Mystery of Long COVID Misery
UCSF will launch the world’s first tissue bank with samples donated by patients with long COVID.
-
Allergists Reveal the Best Time to Start Taking Your Seasonal Allergy Medications